Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

被引:12
|
作者
Bashashati, Mohammad [1 ]
Hejazi, Reza A. [2 ]
Andrews, Christopher N. [3 ]
Storr, Martin A. [1 ,4 ]
机构
[1] Univ Calgary, Gastrointestinal Res Grp, Calgary, AB, Canada
[2] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Internal Med, El Paso, TX USA
[3] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB, Canada
[4] Univ Munich, Div Gastroenterol, Munich, Germany
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 28卷 / 06期
关键词
Gastroesophageal reflux disease; Heartburn; Proton pump inhibitor; NONCARDIAC CHEST-PAIN; MULTICHANNEL INTRALUMINAL IMPEDANCE; DILATED INTERCELLULAR SPACES; IRRITABLE-BOWEL-SYNDROME; EOSINOPHILIC ESOPHAGITIS; SPHINCTER RELAXATIONS; FUNCTIONAL HEARTBURN; VISCERAL HYPERSENSITIVITY; EROSIVE ESOPHAGITIS; HEALTHY-VOLUNTEERS;
D O I
10.1155/2014/904707
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastroesophageal reflux (GER) is a common gastrointestinal process that can generate symptoms of heartburn and chest pain. Proton pump inhibitors (PPIs) are the gold standard for the treatment of GER; however, a substantial group of GER patients fail to respond to PPIs. In the past, it was believed that acid reflux into the esophagus causes all, or at least the majority, of symptoms attributed to GER, with both erosive esophagitis and nonerosive outcomes. However, with modern testing techniques it has been shown that, in addition to acid reflux, the reflux of nonacid gastric and duodenal contents into the esophagus may also induce GER symptoms. It remains unknown how weakly acidic or alkaline refluxate with a pH similar to a normal diet induces GER symptoms. Esophageal hypersensitivity or functional dyspepsia with superimposed heartburn may be other mechanisms of symptom generation, often completely unrelated to GER. Detailed studies investigating the pathophysiology of esophageal hypersensitivity are not conclusive, and definitions of the various disease states may overlap and are often confusing. The authors aim to clarify the pathophysiology, definition, diagnostic techniques and medical treatment of patients with heartburn symptoms who fail PPI therapy.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [1] Comparison of Gastroesophageal Reflux Disease Symptoms and Proton Pump Inhibitor Response Using Gastroesophageal Reflux Disease Impact Scale Questionnaire
    Jo, So Young
    Kim, Nayoung
    Lim, Ji Hwan
    Shin, Cheol Min
    Park, Young Soo
    Lee, Dong Ho
    Jung, Hyun Chae
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 19 (01) : 61 - 69
  • [2] Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms
    Delshad, Sean D.
    Almario, Christopher V.
    Chey, William D.
    Spiegel, Brennan M. R.
    GASTROENTEROLOGY, 2020, 158 (05) : 1250 - +
  • [3] Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease
    Dellon, Evan S.
    Shaheen, Nicholas J.
    GASTROENTEROLOGY, 2010, 139 (01) : 7 - U30
  • [4] Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study
    Kimio Isshi
    Nobuyuki Matsuhashi
    Takashi Joh
    Kazuhide Higuchi
    Katsuhiko Iwakiri
    Takeshi Kamiya
    Noriaki Manabe
    Maiko Ogawa
    Seiji Arihiro
    Ken Haruma
    Koji Nakada
    Journal of Gastroenterology, 2019, 54 : 492 - 500
  • [5] Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study
    Isshi, Kimio
    Matsuhashi, Nobuyuki
    Joh, Takashi
    Higuchi, Kazuhide
    Iwakiri, Katsuhiko
    Kamiya, Takeshi
    Manabe, Noriaki
    Ogawa, Maiko
    Arihiro, Seiji
    Haruma, Ken
    Nakada, Koji
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 492 - 500
  • [6] Exacerbation of gastroesophageal reflux symptoms after discontinuation of proton pump inhibitors is not associated with increased esophageal acid exposure
    Hoshikawa, Yoshimasa
    Nikaki, Kornilia
    Sonmez, Shirley
    Nakagawa, Kenichiro
    Yazaki, Etusro
    Sifrim, Daniel
    Woodland, Philip
    NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32 (01)
  • [7] Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms
    George Triadafilopoulos
    Thomas Zikos
    Kirsten Regalia
    Irene Sonu
    Nielsen Q. Fernandez-Becker
    Linda Nguyen
    Monica Christine R. Nandwani
    John O. Clarke
    Digestive Diseases and Sciences, 2018, 63 : 2673 - 2680
  • [8] Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms
    Triadafilopoulos, George
    Zikos, Thomas
    Regalia, Kirsten
    Sonu, Irene
    Fernandez-Becker, Nielsen Q.
    Nguyen, Linda
    Nandwani, Monica Christine R.
    Clarke, John O.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (10) : 2673 - 2680
  • [9] Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
    de Sa, Claudia Cristina
    Kishi, Humberto Setsuo
    Silva-Werneck, Ana Luiza
    Pinto de Moraes-Filho, Joaquim Prado
    Eisig, Jaime Natan
    Barbuti, Ricardo Correa
    Hashimoto, Claudio Lyioti
    Navarro-Rodriguez, Tomas
    CLINICS, 2011, 66 (04) : 557 - 561
  • [10] Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapy
    Koji Nakada
    Atsushi Oshio
    Nobuyuki Matsuhashi
    Katsuhiko Iwakiri
    Takeshi Kamiya
    Noriaki Manabe
    Takashi Joh
    Kazuhide Higuchi
    Ken Haruma
    Esophagus, 2023, 20 : 309 - 316